entertainment -WSS

entertainment

author：leisure time 2025-08-12 11:33:45 - browse：6535

Fatty liver foregrounds arteries and veins surrounded by red blood cells — health coverage from STAT — Adobe

As drugmakers race to join the obesity drug market ignited by the approval of Wegovy and Zepbound, they’re not just competing on their drugs’ weight loss effects. They’re also competing on their products’ ability to treat a severe form of liver disease.

A new update of the STAT Obesity Drug Tracker shows that at least 23 — about one-fifth — of the 105 obesity treatments in development or on the market are also being investigated for metabolic dysfunction-associated steatohepatitis, the fatty liver disease known as MASH (and previously called NASH).

In this update, STAT has added a category — “other diseases investigated” — to show conditions beyond obesity for which a compound is being studied. Type 2 diabetes is the most common – it’s long been linked to obesity, and the latest GLP-1 treatments like Wegovy and Zepbound were initially developed as diabetes drugs. But behind diabetes, the next most common disease under investigation for obesity candidates is MASH.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Democratic lawmaker calls for 'well

WSS

What STAT readers think about the FDA and patient advocacy

Hospitals owned by private equity see complications spike 25%

Three trends to watch in biotech in 2024

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Boeing's 1st astronaut flight bumped into next year, more repairs needed

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

focus

entertainment

knowledge

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The UK government moves asylum

Dobbs anniversary: the lost opportunity of abortion as health care

Hospitals owned by private equity see complications spike 25%

Duchenne breakthrough therapy leaves behind pioneering families

Hospitals owned by private equity see complications spike 25%

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

Tori Bowie and the unacceptable rates of Black maternal death

Albert Bourla of Pfizer: worst biopharma CEO of 2023

leisure time

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

Judges halt a Biden rule offering student debt relief for those alleging colleges misled them

Carvykti CAR

Violet CEO on training clinicians to promote more inclusive care

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

SEC charges former device maker CEO with $41 million fraud

hotspot

hotspot

knowledge

focus